3rd Conference on Therapeutic Resistance in Cancer
Venue: Hyatt Regency Hotel
|Event Date/Time: Mar 15, 2012||End Date/Time: Mar 17, 2012|
|Registration Date: Mar 08, 2012|
|Early Registration Date: Feb 23, 2012|
Session 1: Intrinsic vs acquired resistance
Session 2: Tumor heterogeneity
Session 3: Host-tumor interactions
Session 4: Biomarker-driven and biopsy-driven trials
Session 5: Challenges of 'omics data
Session 6: Personalized medicine in action
Session 7: New technologies and methodologies
Discussions will focus on the challenges of
therapeutic resistance in personalized medicine, on technical and logistical issues pertaining to personalized medicine, and on creating opportunities for collaborations.
Please visit www.resistanceincancer2012.com for more details on the conference.
Speakers from UCLA Jonsson Comprehensive Cancer Center, University of Colorado, The Translational Genomics Research Institute (TGen), MD Anderson Cancer Center, McGill University, Abramson Cancer Center, Swiss Institute of Bioinformatics, University of California Santa Cruz (UCLA), Ontario Cancer Institute, University of Helsinki, H. Lee Moffitt Cnacer Center, George Mason University's Center for Applied Proteomics and Molecular Medicine.
The deadline for abstracts is February 10, 2012.